2841 Junction Avenue
San Jose, CA 95134
About NeuSpera Medical
Neuspera Medical, headquartered in San Jose, CA, is committed to bringing forward implantable medical device technology that will improve lives of patients battling with chronic illness.
Founder and CTO: Alexander Yeh
CEO: Milton M. Morris
7 articles with NeuSpera Medical
7/21/2021More money means more progress for potentially life-saving therapies. Here's a peek at some biopharma companies adding to their books this week.
Neuspera Medical Inc. today announced the closing of the company's $65 million series C equity financing. The Series C round was co-led by Vertex Ventures HC and Treo Ventures.
6/15/2020It was a fairly busy week with clinical trial updates and announcements. Here’s a look.
Neuspera Medical Completes First Implants of its Neuromodulation Device in its two-stage Pivotal Clinical Trial to treat Urinary Urgency Incontinence
Neuspera Medical Inc., a privately held, clinical stage medical device company, today announced the completion of the first chronic clinical implants of the Neuspera Neuromodulation System on the sacral nerve. The ultra-miniaturized device
Neuspera Medical Receives Investigational Device Exemption for Its Ultra-Miniaturized Implantable Device
Neuspera Medical Inc., a clinical stage, private, venture capital backed neuromodulation company, announced the receipt of an Investigational Device Exemption from the FDA – enabling the company to conduct the first long-term clinical trial of its ultra-miniaturized neuromodulation platform.
Neuspera Medical Inc., a clinical stage, private venture capital backed neuromodulation company, announced the final closing (2nd tranche) of the company's Series B equity financing.
The $26M financing was led by 6 Dimensions Capital with all existing investors from Series A also participating including Action Potential Venture Capital and Windham Venture Partners.